N-[[4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexyl]methyl]thiophene-3-carboxamide
C25H25N7OS — CID 135887088
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexyl]methyl]thiophene-3-carboxamide
N-[[4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexyl]methyl]thiophene-3-carboxamide (PubChem CID 135887088) has the molecular formula C25H25N7OS and a molecular weight of 471.59 g/mol. Its IUPAC name is N-[[4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexyl]methyl]thiophene-3-carboxamide.
Molecular Properties
| Compound Name | N-[[4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexyl]methyl]thiophene-3-carboxamide |
|---|---|
| PubChem CID | 135887088 |
| Molecular Formula | C25H25N7OS |
| Molecular Weight | 471.59 g/mol |
| Exact Mass | 471.18 |
| IUPAC Name | N-[[4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexyl]methyl]thiophene-3-carboxamide |
| SMILES | Nc1ncnn2c(C3CCC(CNC(=O)c4ccsc4)CC3)nc(-c3cc4ccccc4[nH]3)c12 |
| InChI | InChI=1S/C25H25N7OS/c26-23-22-21(20-11-17-3-1-2-4-19(17)30-20)31-24(32(22)29-14-28-23)16-7-5-15(6-8-16)12-27-25(33)18-9-10-34-13-18/h1-4,9-11,13-16,30H,5-8,12H2,(H,27,33)(H2,26,28,29) |
| InChIKey | KFFMCODCJCCKSO-UHFFFAOYSA-N |
| XLogP | 4.62 |
| TPSA | 113.99 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 471.59 |
| LogP ≤ 5 | 4.62 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135887088 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.